Psychedelics Investing Emyria and UWA in Partnership to Commercialise Novel Serotonin-Releasing Agents for Mental Health and Neurology
Psychedelics Investing Emyria Selected by Reach Wellness to Lead MDMA -Assisted Therapy Research for First Responders
Life Science Investing Emyria’s Specialist Psychiatrist Granted Authorised Prescriber Status in MDMA-Assisted Therapy for PTSD
cannabis investing Eminent Healthcare Leader Appointed as Independent Non-Executive Chairman for Emyria Ltd
Precious Metals & Critical Minerals Hybrid Investor Conference: Presentations Now Available for Online Viewing
